Home LiteratureArticle Details
PMID: 19870979 Published · ppublish English Journal Article

THE SIGNIFICANCE OF M AND T ANTIGENS IN THE CROSS REACTIONS BETWEEN CERTAIN TYPES OF GROUP A HEMOLYTIC STREPTOCOCCI.

The Journal of experimental medicine ·Vol. 71 ·No. 4 ·1940-03-31 ·Pages 539-50

Lancefield RC

Abstract

In any one strain the occurrence of the previously recognized type-specific protein, M, is usually completely correlated with the presence of the recently recognized type-specific antigen, T. Strain C203 is exceptional in having the T substance of type 1 as well as the two type-specific antigens, M and T, characteristic of type 3. It does not have the M antigen of type 1. While other strains with similar antigenic peculiarities have not been encountered, it is probable that they occur, and the existence of such anomalies must be suspected when unusual serological reactions occur.

Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Lancefield R C
Hospital of The Rockefeller Institute for Medical Research.
References (3)
3 references, click to expand
  1. STUDIES ON THE SEROLOGICAL TYPING OF STREPTOCOCCUS HEMOLYTICUS.
    J Exp Med. 1937 Mar 31;65(4):595-612 PMID: 19870621
  2. ANTIGENIC PROPERTIES OF THE TYPE-SPECIFIC SUBSTANCE DERIVED FROM GROUP A HEMOLYTIC STREPTOCOCCI.
    J Exp Med. 1939 Feb 28;69(3):425-45 PMID: 19870855
  3. TYPE-SPECIFIC ANTIGENS, M AND T, OF MATT AND GLOSSY VARIANTS OF GROUP A HEMOLYTIC STREPTOCOCCI.
    J Exp Med. 1940 Mar 31;71(4):521-37 PMID: 19870978
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1940-03-31
Pages
539-50
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2135090
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com